A phase 3 trial of patients with moderate-to-severe TED has shown that subcutaneous injection of Tepezza by way of an on-body ...
Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.
Amgen (AMGN) stock climbs as MariTide GLP-1 trials demonstrate nearly 20% weight loss. Truist raises price target to $325 ...
One of the world’s largest biotechnology companies is planning a major expansion at its headquarters in Southern California, even as some life sciences landlords struggle to fill already-delivered ...
Adjusted EPS $4.90 vs LSEG estimate of $4.30 Revenue of $8.1 billion in line with Wall Street estimates 2025 outlook reaffirmed May 1 (Reuters) - Amgen (AMGN.O), opens new tab on Thursday said its ...
CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha® (evolocumab injection) ...
Amgen Inc. (NASDAQ:AMGN) is included among the 13 NASDAQ Stocks with Highest Dividends. On April 10, Morgan Stanley analyst ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results